IV Catheters, Notched Needle

With the push of a button, the needle instantly retracts reducing the risk of accidental needlestick injuries.

BD Vialon™, a unique proprietary biomaterial, has been proven to enhance clinical and economic outcomes.

• Increases the ease of penetration
• Reduces the risks of infiltration
• Exhibits greater kink resistance
• Reduces the risks of phlebitis up to 50%
• Reduces IV restarts due to reduced complications
• Increases indwelling time
• Reduces the total IV therapy costs to use due to longer indwelling times

Notched needle technology provides rapid visualization of blood return along the catheter shaft. It is an excellent choice for fragile vessels or vessels that have lost venous tone:

• Any chronically ill patient who has compromised vein status
• Neonates
• Geriatrics

Becton, Dickinson and Company (BD) is a global medical technology leader providing a broad range of products across medication management, diagnostics, and surgical care. BD’s Medical segment includes industry-leading solutions in medication delivery, such as BD syringes, needles, and infusion systems, as well as devices for diabetes care and pharmaceutical pre-fillable systems. The Life Sciences division supports clinical diagnostics and research with products like BD Vacutainer blood collection systems and BD Veritor rapid testing platforms. BD’s Interventional segment includes advanced surgical products from acquired brands like Bard and Tepha, with specialties in infection prevention, hernia repair, biosurgery, and urology. With a focus on advancing health through technology, BD supports hospitals, labs, and clinicians worldwide in improving safety, efficiency, and patient outcomes.